Now published: the 19th Edition, May 2026
The Worldwide Market for IVD Tests, 19th Edition
The global IVD market reached $115.6 billion in 2025 and is projected to reach $150.4 billion by 2030, a 5.4% compound annual growth rate. Growth is concentrating in technology-driven, decentralized testing such as continuous glucose monitoring and molecular oncology. See which segments, regions and companies will drive the next five years.
Continuous Glucose Monitoring · Molecular Oncology · Molecular HPV · Clinical Chemistry · Point of Care · and 20+ segments
Part of the SMG Market Research Reports portfolio, six research products for life science and diagnostics commercial teams
An internationally recognized benchmark in the diagnostics field
$150.4B
Market by 2030
5.4%
CAGR, 2025 to 2030
20+
IVD Segments
1,138
Pages of Intelligence
FREE PREVIEW
Not ready to purchase? Start with a free preview.
Download the free sample report from The Worldwide Market for IVD Tests, 19th Edition. See the depth of the market data, the structure of the segment analysis and the five-year forecasts before you commit.
What's Included List
- The complete table of contents for all 1,138 pages
- Executive summary overview, scope and methodology
- Global IVD sales by product segment, 2025 to 2030, with growth rates
- A guide to finding every topic in the 19th Edition
- Selected market sections, including companion diagnostics
No commitment required. See the full depth of the report before you buy.
The Worldwide Market for IVD Tests: 20+ IVD segments. One comprehensive source.
Kalorama Information’s 19th Edition of The Worldwide Market for IVD Tests examines how IVD industry participants are handling competitive pressure, cost constraints and changing healthcare needs while positioning for growth through 2030. It was published on May 21, 2026.
The report covers the global IVD market with forecasts for 2025 to 2030 in U.S. dollars, with segment analysis by test category and, where possible, analyte. Market size is based on manufacturer revenues, not retail or reimbursement pricing. It is built for senior executives, marketers and strategic decision makers.
The 19th Edition is the latest release of Kalorama’s flagship IVD report. Since the 18th Edition, three themes have defined the industry: portfolio expansion, customization and digital health. The 19th Edition forecasts the IVD market from 2025 to 2030 and examines how companies are prioritizing portfolio and menu expansion over entirely new platforms.
Market intelligence across every major IVD segment
The 19th Edition sizes and forecasts more than 20 IVD segments from 2025 to 2030. Kalorama groups them by projected growth:
Double-digit growth segments
Continuous Glucose Monitoring · Direct-to-Consumer Genetic Testing · Molecular Oncology · Molecular HPV Testing
High single-digit growth segments
Clinical Sequencing · Hematology · Histology and Cytology · Mass Spectrometry · Molecular Blood Bank Testing · Molecular Genetic and Inherited Disease Testing · Prenatal Test Services
Mid single-digit growth segments
Circulating Tumor Cells · Clinical Chemistry · Flow Cytometry · Other Immunoassays · Lab-Based HbA1c Immunoassays · Molecular Microbiology · Other POC/OTC Testing · Professional POC Testing
Low single-digit growth segments
Blood Bank Screening · Blood Grouping and Typing · Coagulation · COVID-19 · D-dimer · Drugs of Abuse · Infectious Disease Immunoassays · Microbiology (ID/AST) · POC/OTC Diabetes Testing
Read links:
FREE ANALYST BRIEFING
Webinar on Demand
The State of the Instrumentation Market: Key Insights from SDi's 2026 Global Assessment
Free Virtual Briefing · 40+ minutes + Q&A · Now available on demand
Speakers: Mike Tice, SVP Syndicated Research · Justin Saeks, Senior Market Analyst · Daniel Granderson, Senior Editor, Kalorama
Watch the full 40+ minute analyst briefing and Q&A at your convenience.
The Global IVD Market, 2025 to 2030
A first look at market growth, segment shifts and competitive dynamics from The Worldwide Market for IVD Tests, 19th Edition.
REPORT CONTENTS
What’s inside the 19th Edition
The 19th Edition delivers:
-
Market size and five-year forecasts for every major IVD segment, 2025 to 2030
-
Which segments are growing at double digits, and which are flat or modest
-
Country and regional forecasts, including the U.S., Europe, Japan, China, India and fast-growing emerging markets
-
Revenue rankings and profiles of the top IVD companies
-
Mergers and acquisitions, partnerships and the strategic shifts reshaping the industry
-
Dedicated sections on artificial intelligence, next-generation sequencing, liquid biopsy, companion diagnostics, gene editing and the microbiome
“Continuous glucose monitoring is the segment that breaks the mature-market narrative. It isn’t just a test anymore; it’s becoming the front door to remote monitoring and personalized care.”
Dr. Melissa Dueck, Senior Market Analyst, Kalorama Information
NOW AVAILABLE
Purchase The Worldwide Market for IVD Tests, 19th Edition
Questions about licensing? Contact our team
IVD Test Procedure Volumes, 8th Edition
Not just where the IVD market is going, but where the testing is and what it’s worth.
The world runs on roughly 150 billion diagnostic tests a year, and that number is climbing faster than the revenue behind it. IVD Test Procedure Volumes, 8th Edition tracks global procedure volumes segment by segment and region by region, with product sales and per-procedure cost dynamics across 13 testing categories. It is the essential companion to The Worldwide Market for IVD Tests, 19th Edition.
PUBLISHED: September 8, 2026
PAGES: 283
TESTING CATEGORIES: 13
FORECAST: 2025 to 2030
An Internationally Recognized Benchmark in the Diagnostics Field
Kalorama Information launched in 1998. The Worldwide Market for IVD Tests combines industry expertise, extensive secondary research and interviews with market participants, with an emphasis on corporate developments, financial performance and vendor activity.
Kalorama is part of Science and Medicine Group, an expanding collection of research and advisory companies spanning the laboratory, scientific, and medical space.
FAQs
What is The Worldwide Market for IVD Tests, 19th Edition?
Kalorama Information’s 19th Edition examines how IVD industry participants are handling competitive pressure, cost constraints and changing healthcare needs while positioning for growth through 2030. It was published on May 21, 2026.
How big is the IVD market, and where is it headed?
Kalorama reports that the global IVD market reached $115.6 billion in 2025. It projects $150.4 billion by 2030, a 5.4% compound annual growth rate.
What is new since the 18th Edition?
Since the 18th Edition, Kalorama has identified three areas of concentration across the industry: portfolio expansion, customization and digital health. Research for the 19th Edition shows companies prioritizing portfolio and menu expansion over entirely new platforms.
Which IVD segments are growing fastest?
Continuous glucose monitoring, molecular oncology, molecular HPV and direct-to-consumer genetic testing are growing at double digits. More mature categories such as blood banking, coagulation and traditional infectious disease immunoassays are growing at low single digits.
What does the report cover?
It covers the global IVD market with forecasts for 2025 to 2030 in U.S. dollars, with segment analysis by test category and, where possible, analyte. Market size is based on manufacturer revenues, not retail or reimbursement pricing.
Who should read it?
Senior executives, marketers and strategic decision makers.
What license options are available?
Online + Download (unlimited users), or Online only (3 users, no downloads).